Prudential Financial Inc Next Cure, Inc. Transaction History

Prudential Financial Inc

  • $70.8 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
BUY
$21.19 - $40.2 $18,689 - $35,456
882 Added 3.48%
26,192 $561,000
Q1 2020

May 12, 2020
BUY
$32.32 - $58.37 $818,019 - $1.48 Million
25,310 New
25,310 $938,000

Others Institutions Holding NXTC

# of Institutions
44
Shares Held
14.6M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $8.6M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email